While influenza, respiratory syncytial virus (RSV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) present distinct clinical profiles, there is a substantial overlap in the populations most vulnerable to severe disease. Advanced age, multiple comorbidities, and immunocompromised states universally put individuals at the highest risk when facing these respiratory viral threats. To address this ongoing […]




